Update information
April 2026: This quality standard was updated, and the placeholder statement (statement 2) prioritised in 2025 was updated alongside the publication of updated recommendations in NICE's guideline on suspected cancer to support it.
Statements are marked as [2025, updated 2026] if the statement covers an area for quality improvement included in the quality standard update (2025) and has been updated.
February 2025: This quality standard was updated, and statements prioritised in 2012 were replaced. The topic was identified for update following a review of quality standards. The review identified new guidance on ovarian cancer: identifying and managing familial and genetic risk.
Statements are marked as [2025] if the statement covers a new area for quality improvement.
The previous version of the quality standard for ovarian cancer is available as a pdf.
Minor changes since publication
April 2025: Source guidance references were updated to align with changes to NICE's guideline on ovarian cancer: recognition and initial management.